🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Papers
Distinct relapse pattern across molecular ependymoma types

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Distinct relapse pattern across molecular ependymoma types

Neuro-Oncology(2024)10.1093/neuonc/noae166Source: DataRank Database

Distinct relapse pattern across molecular ependymoma types is a research paper published in Neuro-Oncology (2024). On theSindex it has a DataRank of 0.312. It has been cited 7 times.

N/A

0.312DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: bronzeTopics (68)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

FFindable (1/2)

Has DOI

AAccessible (1/2)

Open Access

IInteroperable (0/2)

RReusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.312

From this paper's citation signal

Citation Network Contribution

0

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (27)

Melanie Schoof ORCID,Alicia Eckhardt,Martin Mynarek ORCID,Mark R. Gilbert ORCID,Kenneth Aldape ORCID

Live enrichment

PubMed:39171767

Deutsche Forschungsgemeinschaft

Grant: SCHU2442/8-1

German Children Cancer Foundation

Grant: DKS 2006.01

German Children Cancer Foundation

Grant: DKS 2008.07

German Children Cancer Foundation

Grant: DKS 2012.03

German Children Cancer Foundation

Grant: DKS 2015.02

German Children Cancer Foundation

Grant: DKS 2017.12

German Children Cancer Foundation

Grant: DKS 2020.02

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

Collaborative Ependymoma Research Network

Neuroradiology and Neuropathology of the German

bronzeLicense: OUP Standard Publication Reuse

publisherhttps://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noae166/58889628/noae166.pdf

publisherhttps://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noae166/59750378/noae166.pdf

publisherhttps://academic.oup.com/neuro-oncology/article-pdf/27/1/267/59750378/noae166.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11726240/pdf/noae166.pdf

https://doi.org/10.1093/neuonc/noae166

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicineHumansEpendymomaNeoplasm Recurrence, LocalFemaleMaleChildAdolescentAdultChild, PreschoolYoung AdultDNA MethylationBrain NeoplasmsMiddle AgedFollow-Up StudiesPrognosisInfantSurvival RateDNA Copy Number VariationsBiomarkers, TumorAged

MeSH Terms

HumansEpendymomaNeoplasm Recurrence, LocalFemaleMaleChildAdolescentAdultChild, PreschoolYoung AdultDNA MethylationBrain NeoplasmsMiddle AgedFollow-Up StudiesPrognosisInfantSurvival RateDNA Copy Number VariationsBiomarkers, TumorAged

Keywords

MaleAdultependymomarecurrenceAdolescentDNA Copy Number VariationsMedizinYoung AdultBiomarkers, TumorHumansChildAgedrelapseBrain NeoplasmsInfantDNA MethylationMiddle AgedPrognosismetastaticSurvival RateChild, PreschoolFemaleNeoplasm Recurrence, LocalPediatric Neuro-OncologyFollow-Up Studies

Sustainable Development Goals

SDG 3: 3. Good health

Related Papers (10)

Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q

N/A

2.7DataRank · unranked

Neuro-Oncology(2021)

co-citedsame journal

10.1093/neuonc/noab034

Spatial transcriptomic analysis delineates epithelial and mesenchymal subpopulations and transition stages in childhood ependymoma

Neuro-Oncology(2022)

co-citedsame journal

10.1093/neuonc/noac219

Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study

Neuro-Oncology(2023)

co-citedsame journal

10.1093/neuonc/noad096

Integrated transcriptomic landscape of medulloblastoma and ependymoma reveals novel tumor subtype-specific biology

Top 72%

0.112DataRank

Neuro-Oncology(2025)

co-citedsame journal

10.1093/neuonc/noaf251

Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma

N/A

0.427DataRank · unranked

Clinical Cancer Research(2024)

co-cited

10.1158/1078-0432.ccr-23-3156

A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma

N/A

0.621DataRank · unranked

Neuro-Oncology(2020)

co-citedsame journal

10.1093/neuonc/noaa240

ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma

N/A

0.681DataRank · unranked

Cancer Discovery(2021)

co-cited

10.1158/2159-8290.cd-20-1066

Recurrent ACVR1 mutations in posterior fossa ependymoma

N/A

0.449DataRank · unranked

Acta Neuropathologica(2022)

co-cited

10.1007/s00401-022-02435-2

Phase II study of everolimus for recurrent or progressive pediatric ependymoma

N/A

0.344DataRank · unranked

Neuro-Oncology Advances(2023)

co-cited

10.1093/noajnl/vdad011

Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma

N/A

3.8DataRank · unranked

Cancer Cell(2020)

co-cited

10.1016/j.ccell.2020.06.004